STOCKHOLDERS' EQUITY (Details) - USD ($)																			1 Months Ended				3 Months Ended								9 Months Ended			12 Months Ended
		Sep. 30, 2025	Sep. 03, 2025	Jul. 16, 2025	Jul. 15, 2025	Feb. 24, 2025	Feb. 18, 2025	Feb. 10, 2025	Feb. 06, 2025	Feb. 05, 2025	Jan. 30, 2025	Jan. 28, 2025	Nov. 06, 2024	Aug. 01, 2024	Jul. 26, 2024	Jul. 22, 2024	Jul. 12, 2024	Mar. 31, 2022	Jul. 31, 2025	Sep. 30, 2024		Jul. 31, 2024	Sep. 30, 2025		Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024		Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Sep. 30, 2024		Dec. 31, 2024	Jan. 31, 2025
Stockholders’ Equity [Line Items]
Common stock shares authorized	[1]	150,000,000																					150,000,000								150,000,000			150,000,000
Common stock par value (in dollars per share)	[1]	$ 0.0001																					$ 0.0001								$ 0.0001			$ 0.0001
Common stock, shares issued	[1]	4,104,469																					4,104,469								4,104,469			566,908
Common stock outstanding	[1]	4,104,469																					4,104,469								4,104,469			566,908
Reverse stock split						1:5	1:5	On February 10, 2025, the Board of Directors approved a 1:5 reverse split ratio. On February 24, 2025, the Company effected the 1:5 reverse stock split (the “1:5 Reverse Stock Split”, and together with the 1:12 Reverse Stock Split, the “Reverse Stock Splits”).					On November 6, 2024, a majority of the Company’s stockholders approved an additional reverse stock split at a split ratio ranging between 1:3 and 1:5, as determined by the Board of Directors in its sole discretion.									Following stockholder approval in July 2024, the Company effected a reverse stock split at a ratio of 1:12, which was effective as of August 12, 2024 (the “1:12 Reverse Stock Split”).									1:5
Additional common share												204,312
Sale of stock price per share (in dollars per share)										$ 3.575		$ 5.105
Exercise of warrants												408,621
Exercise price of warrants (in dollars per share)												$ 3.855
Net proceeds from Private Placement									$ 908,627		$ 804,346																					$ 3,414,502
Aggregate shares of common stock										300,700
Dividends percentage																																		6.00%
Dividends preferred stock																															1,076,975
Shares converted																		18,473
Proceeds from Exercise of Pre-Funded Warrants																															$ 2,804	$ 9,990
Placement Agent Warrants [Member]
Stockholders’ Equity [Line Items]
Exercise of warrants										22,554																									15,325
Exercise price of warrants (in dollars per share)										$ 4.469																									$ 6.382
Warrants, each warrant to purchase one share of Common Stock
Stockholders’ Equity [Line Items]
Exercise price of warrants (in dollars per share)										$ 2.95
Number of Warrants, Exercised																							878,264			(385,200)			(8,326)	(8,326)
Number of warrants granted																							6,338,788	[2]		747,200	1,782,612			140,884
Number of warrants exercisable		7,587,594																		756,680	[3]		7,587,594				756,680	[3]			7,587,594	756,680	[3]
Weighted average exercise price (in dollars per share)																							$ 0.001			$ 0.01			$ 0.6	$ 0.6
Pre-Funded Warrant [Member]
Stockholders’ Equity [Line Items]
Sale of stock price per share (in dollars per share)					$ 1.899
Units issued					878,264
Warrant shares		0																					0		0	0					0
Number of Warrants, Exercised																							878,264				0				1,263,464	16,652
Proceeds from Exercise of Pre-Funded Warrants																							$ 878				$ 0				$ 2,804	$ 9,990
Number of warrants granted																			878,264	579,711
Number of warrants exercisable		0																		385,200			0		0	0	385,200				0	385,200
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)																							878,264				0				1,263,464	16,652
Class of Warrant or Right, Outstanding		0																					0		0	0					0
Series A Warrants [Member]
Stockholders’ Equity [Line Items]
Number of warrants granted																				579,711
Series B Warrants [Member]
Stockholders’ Equity [Line Items]
Warrants exercisable expiry term																				18 months							18 months					18 months
Number of warrants granted																				579,711
September 2024 Agent Warrants [Member]
Stockholders’ Equity [Line Items]
Number of warrants granted																				43,479
July 2025 Pre-Funded Warrants [Member]
Stockholders’ Equity [Line Items]
Exercise price of warrants (in dollars per share)					$ 0.001
Date from which warrants exercisable					Jul. 16, 2025
July 2025 A-1 Warrants [Member]
Stockholders’ Equity [Line Items]
Exercise price of warrants (in dollars per share)					$ 1.9
Date from which warrants exercisable					Jul. 16, 2025
Date of warrants exercisable expiry					Jul. 15, 2030
July Two Thousand Twenty Five A Two Warrants [Member]
Stockholders’ Equity [Line Items]
Exercise price of warrants (in dollars per share)					$ 1.9
Date from which warrants exercisable					Jul. 16, 2025
Date of warrants exercisable expiry					Jan. 15, 2027
July 2025 Placement Agent Warrants [Member]
Stockholders’ Equity [Line Items]
Warrants exercisable expiry term					5 years
Exercise price of warrants (in dollars per share)					$ 2.375
Date from which warrants exercisable					Jul. 16, 2025
Date of warrants exercisable expiry					Jul. 15, 2030
July 2025 Placement Agent Warrants [Member] | Maximum [Member]
Stockholders’ Equity [Line Items]
Aggregate shares of common stock					197,368
July 2025 Offering [Member]
Stockholders’ Equity [Line Items]
Sale of stock price per share (in dollars per share)					$ 1.9
Net proceeds from Private Placement				$ 4,281,300
Units issued					1,753,314
Common Stock, par value $0.0001 per share
Stockholders’ Equity [Line Items]
Purchase of common stock																											14,667
Shares converted															6,667	8,000
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)																							878,264			385,200			8,326	8,326
WallachBeth Capital LLC [Member]
Stockholders’ Equity [Line Items]
Common stock aggregate offering price																	$ 1,253,603
ATM Offering														135,568
Gross proceeds														$ 1,994,583
Sales agreement termination date			Sep. 03, 2025
H C Wainwright And Co LLC [Member]
Stockholders’ Equity [Line Items]
Exercise of warrants		43,479																					43,479								43,479
Exercise price of warrants (in dollars per share)		$ 8.63																					$ 8.63								$ 8.63
H C Wainwright And Co LLC [Member] | 2025 ATM Agreement [Member]
Stockholders’ Equity [Line Items]
ATM Offering		0
Common stock aggregate gross sales proceeds authorized			$ 1,397,532
Sales agent commission percentage			3.00%
Series A Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred stock shares authorized		1,000,000																					1,000,000								1,000,000			1,000,000
Preferred stock shares, par value (in dollars per share)		$ 0.0001																					$ 0.0001								$ 0.0001			$ 0.0001
Preferred stock shares issued		76,480																					76,480								76,480			76,480
Preferred stock shares outstanding		76,480																					76,480								76,480			76,480
Reverse stock split																															as adjusted for the 1:12 Reverse Stock Split after August 12, 2024 and the 1:5 Reverse Stock Split after February 24, 2025
Warrants exercisable expiry term																				5 years							5 years					5 years
Dividends percentage																															19.90%
Dividends preferred stock																							$ 128,097				$ 116,571				$ 372,960	$ 352,333
Common stock conversion price per share (in dollars per share)																															$ 100
Convertible Preferred Stock, Shares Issued upon Conversion															1,032	1,291
Preferred stock, convertible, shares issuable		0																		2,323			0				2,323				0	2,323
Series A Non-Voting Convertible Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Designated shares		80,965																80,965					80,965								80,965
Common Stock, par value $0.0001 per share | Warrants, each warrant to purchase one share of Common Stock
Stockholders’ Equity [Line Items]
Aggregate shares of common stock										300,700
Convertible Common Stock [Member]
Stockholders’ Equity [Line Items]
Common stock, shares issued		0																		14,667			0				14,667				0	14,667
IPO [Member]
Stockholders’ Equity [Line Items]
Sale of stock price per share (in dollars per share)		$ 300																					$ 300								$ 300

[1] Prior periods presented have been adjusted to reflect the 1:5 reverse stock split on February 24, 2025.

[2] Weighted average remaining contractual life excludes 878,264 Pre-Funded Warrants issued July 2025 that do not have a contractual expiration date, for which 0 warrants remain outstanding and exercisable at September 30, 2025.

[3] Weighted average remaining contractual life calculation excludes 579,711 exercisable Pre-Funded Warrants issued September 2024 that do not have a contractual expiration date.